Monitor Orthopaedic Footwear Questionnaire (MOS) Validity and Reliability Study
Launched by MEDIPOL UNIVERSITY · Jun 13, 2025
Trial Information
Current as of August 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The translation procedure and cross-cultural adaptation of the MOS will be carried out according to the predetermined cross-cultural adaptation principles of Beaton et al. For the development of the Turkish adaptation of the MOS and the validity and reliability study, permission was obtained by e-mail from Jaap Van Netten, the first author of the original questionnaire. Firstly, two independent translators will translate the original questionnaire from English to Turkish. One of the translators will be informed about the study, the other will not be informed about the study. A draft version...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Wearing orthopedic shoes for the first time,
- • Being 16 years old and above,
- • Being a native Turkish speaker and having at least a literacy level,
- • Being able to complete the survey without assistance regarding cognitive or physical disorders,
- • Volunteering to participate in the study
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beykoz, Istanbul, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported